Fennec Pharmaceuticals (FENC) Return on Equity (2016 - 2025)
Historic Return on Equity for Fennec Pharmaceuticals (FENC) over the last 15 years, with Q3 2025 value amounting to 1.08%.
- Fennec Pharmaceuticals' Return on Equity rose 7900.0% to 1.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.08%, marking a year-over-year increase of 7900.0%. This contributed to the annual value of 0.05% for FY2024, which is 22100.0% down from last year.
- According to the latest figures from Q3 2025, Fennec Pharmaceuticals' Return on Equity is 1.08%, which was up 7900.0% from 1.73% recorded in Q2 2025.
- Fennec Pharmaceuticals' 5-year Return on Equity high stood at 321.08% for Q3 2023, and its period low was 231.58% during Q4 2022.
- Over the past 5 years, Fennec Pharmaceuticals' median Return on Equity value was 0.13% (recorded in 2024), while the average stood at 6.34%.
- Per our database at Business Quant, Fennec Pharmaceuticals' Return on Equity surged by 3247600bps in 2023 and then tumbled by -3208000bps in 2024.
- Fennec Pharmaceuticals' Return on Equity (Quarter) stood at 0.79% in 2021, then plummeted by -29098bps to 231.58% in 2022, then skyrocketed by 107bps to 15.41% in 2023, then tumbled by -100bps to 0.03% in 2024, then surged by 3388bps to 1.08% in 2025.
- Its Return on Equity was 1.08% in Q3 2025, compared to 1.73% in Q2 2025 and 2.36% in Q1 2025.